Have a personal or library account? Click to login
Challenges in the Management of Long-Therm Corticotherapy Treatment at Smoker Pacient with Severe Asthma Cover

Challenges in the Management of Long-Therm Corticotherapy Treatment at Smoker Pacient with Severe Asthma

Open Access
|Aug 2023

References

  1. Selroos, Olof, et al. National and Regional Asthma “ Programmes in Europe.” European Respiratory Review, vol. 24, no. 137, 31 Aug. 2015, pp. 474–483, https://doi.org/10.1183/16000617.00008114.
  2. Wang, Eileen, et al. Characterization of Severe “ Asthma Worldwide.” Chest, vol. 157, no. 4, Apr. 2020, pp. 790–804, https://doi.org/10.1016/j.chest.2019.10.053.
  3. Thomson, N.C. Asthma and Cigarette Smoking.” “European Respiratory Journal, vol. 24, no. 5, 1 Nov. 2004, pp. 822–833, erj.ersjournals.com/content/24/5/822, https://doi.org/10.1183/09031936.04.00039004.
  4. Tiotiu, Angelica, et al. The Impact of Tobacco “Smoking on Adult Asthma Outcomes.” International Journal of Environmental Research and Public Health, vol. 18, no. 3, 23 Jan. 2021, p. 992, www.ncbi.nlm.nih.gov/pmc/articles/PMC7908240/, https://doi.org/10.3390/ijerph18030992.
  5. Bachelez, Hervé, et al. Generalized Pustular “Psoriasis Is a Disease Distinct from Psoriasis Vulgaris: Evidence and Expert Opinion.” Expert Review of Clinical Immunology, vol. 18, no. 10, 1 Oct. 2022, pp. 1033–1047, pubmed.ncbi.nlm.nih.gov/36062811/, https://doi.org/10.1080/1744666X.2022.2116003. Accessed 12 July 2023.
  6. Mao, Bei, et al. Asthma and Bronchiectasis “Exacerbation.” European Respiratory Journal, vol. 47, no. 6, 1 June 2016, pp. 1680–1686, erj.ersjournals.com/content/47/6/1680, https://doi.org/10.1183/13993003.01862-2015.
  7. Yang, Bumhee, et al. Association between Smoking “Status and Incident Non-Cystic Fibrosis Bronchiectasis in Young Adults: A Nationwide Population-Based Study.” Journal of Personalized Medicine, vol. 12, no. 5, 26 Apr. 2022, p. 691, https://doi.org/10.3390/jpm12050691.
  8. Mahler, Beatrice. “Assessing the Quality of Life with CAT in Bronchiectasis Patients.” European Respiratory Journal, vol. 38, no. Suppl 55, 1 Sept. 2011, erj.ersjournals.com/content/38/Suppl_55/p943. Accessed 12 July 2023.
  9. Guy G. Brusselle, M.D., Ph.D., and Gerard H. Koppelman, Biologic Therapies for Severe Asthma, N Engl J Med 2022;386:157-71.DOI: 10.1056/NEJMra 2032506
  10. Tiotiu, Angelica, et al. Does Asthma-Bronchiectasis “ Overlap Syndrome (ABOS) Really Exist?” Journal of Asthma, 18 Apr. 2023, pp. 1–11, https://doi.org/10.1080/02770903.2023.2203743. Accessed 22 Apr. 2023.
  11. Perez-Miranda, Javier, et al. Bronchiectasis in “Severe Asthma.” Current Opinion in Pulmonary Medicine, vol. 25, no. 1, Jan. 2019, pp. 71–78, https://doi.org/10.1097/mcp.0000000000000542. Accessed 31 Oct. 2022.
  12. Damiani, Giovanni, et al. The Global, Regional, and “National Burden of Psoriasis: Results and Insights from the Global Burden of Disease 2019 Study.” Frontiers in Medicine, vol. 8, 16 Dec. 2021, https://doi.org/10.3389/fmed.2021.743180.
  13. Wang, Jian, et al. “Association between Psoriasis and Asthma Risk: A Meta-Analysis.” Allergy and Asthma Proceedings, vol. 39, no. 2, 1 Mar. 2018, pp. 103–109, https://doi.org/10.2500/aap.2018.39.4109. Accessed 12 Dec. 2020.
  14. Busse, William W. Asthma and Psoriasis: What Do “They Have in Common? IL-17A!” Journal of Allergy and Clinical Immunology, vol. 144, no. 5, Nov. 2019, pp. 1169–1171, https://doi.org/10.1016/j.jaci.2019.09.006. Accessed 6 June 2020.
  15. Zazzali, James L., et al. Risk of Corticosteroid-“Related Adverse Events in Asthma Patients with High Oral Corticosteroid Use.” Allergy and Asthma Proceedings, vol. 36, no. 4, 1 July 2015, pp. 268–274, https://doi.org/10.2500/aap.2015.36.3863. Accessed 30 Jan. 2020.
  16. Orsi, Fernanda A., et al. Glucocorticoid Use and Risk “ of First and Recurrent Venous Thromboembolism: Self-Controlled Case-Series and Cohort Study.” British Journal of Haematology, vol. 193, no. 6, 21 Mar. 2021, pp. 1194–1202, https://doi.org/10.1111/bjh.17388. Accessed 8 July 2022.
  17. Heinrich, Matthew, et al. Erythrodermic Psoriasis “Secondary to Systemic Corticosteroids.” Baylor University Medical Center Proceedings, vol. 33, no. 1, 11 Nov. 2019, pp. 113–114, https://doi.org/10.1080/08998280.2019.1686911. Accessed 6 Dec. 2021.
  18. Liao, Wilson, et al. Erythrodermic Psoriasis: “ Pathophysiology and Current Treatment Perspectives.” Psoriasis: Targets and Therapy, vol. Volume 6, July 2016, pp. 93–104, https://doi.org/10.2147/ptt.s101232.
DOI: https://doi.org/10.2478/inmed-2023-0252 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 109 - 116
Published on: Aug 8, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Andreea-Dumitriţa Slabu, Maria-Beatrice Catrangiu, Ana-Luiza Iorga, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.